Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma

Abstract

Asthma: Traps to target for treatment Controlling the formation of mesh-like structures of DNA and protein which induce airway damage in asthma could offer new therapeutic opportunities, especially for patients who do not respond well to conventional treatments. The structures are produced by activated cells as part of the immune response in asthma. They are known as eosinophil extracellular traps (EETs) since they are most prominently released by the activity of white blood cells called eosinophils. Hae-Sim Park and colleagues at Ajou University in South Korea studied the involvement of EETs in patients with severe asthma. Their results suggest eosinophils are more activated to create damaging EETs in patients with severe asthma than in those with less severe forms of the disease. Searching for ways to control EET formation could be a fruitful approach to helping patients with severe eosinophilic asthma.